<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AA7CF37A-1A3C-4DC6-8488-4445B285ACA2"><gtr:id>AA7CF37A-1A3C-4DC6-8488-4445B285ACA2</gtr:id><gtr:name>Genentech</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/289F7529-FA9B-42C2-B4C7-4603DA25CC42"><gtr:id>289F7529-FA9B-42C2-B4C7-4603DA25CC42</gtr:id><gtr:name>Ludwig Institute for Cancer Research</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Lymphocyte Signalling and Development</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AA7CF37A-1A3C-4DC6-8488-4445B285ACA2"><gtr:id>AA7CF37A-1A3C-4DC6-8488-4445B285ACA2</gtr:id><gtr:name>Genentech</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/289F7529-FA9B-42C2-B4C7-4603DA25CC42"><gtr:id>289F7529-FA9B-42C2-B4C7-4603DA25CC42</gtr:id><gtr:name>Ludwig Institute for Cancer Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E5AB7E3C-876B-4608-8B8A-C7EC86B34584"><gtr:id>E5AB7E3C-876B-4608-8B8A-C7EC86B34584</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Turner</gtr:surname><gtr:orcidId>0000-0002-3801-9896</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601618"><gtr:id>7559A32A-9CFE-4BA6-8F98-2AB0AE343518</gtr:id><gtr:title>Molecular mechanisms of B Lymphocyte differentiation and activation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601618</gtr:grantReference><gtr:abstractText>Antibodies produced B cells are key mediators of immunity that protect us from pathogenic micro-organisms such as bacteria and viruses. The production of high affinity antibodies is central to immunity and the principle of vaccination. However, self-reactive antibodies are common in human autoimmune diseases. Therapies that deplete B cells are proving successful in common but crippling diseases such as Rheumatoid Arthritis. Cancers of B cell origin comprise the majority of lymphoid malignancies and many B cell malignancies remain incurable. Thus the study of B lymphocytes in health and disease is directly relevant to our attempts to improve vaccine design; to develop new treatments for autoimmune disease; and to develop therapies to combat B cell malignancies. 

The objective of reducing morbidity and mortality associated with diseases where B cell play a role requires a fuller understanding of the molecular mechanisms that regulate B cell activation and differentiation. This project seeks to uncover mechanisms that control the development and function of B cells. The project proposes to test the hypothesis that the activity of key genes required for B cell differentiation are regulated by a novel mechanism acting on the messenger RNA. If correct, it will change the way we think about B cell differentiation.</gtr:abstractText><gtr:technicalSummary>B cells play key roles in both health and disease and further understanding of the molecular regulation of B cell differentiation is important for progress in vaccine design and for the development of therapies to treat autoimmunity and B cell malignancies. 
The importance of a regulatory network of transcription factors controlling B cell identity, the germinal centre (GC) response and plasma cell differentiation is well established. However, important mechanistic gaps in our knowledge remain. In particular, the relative role of post-transcriptional control in the regulation of B cell differentiation remains unclear. We have limited knowledge of the signalling mechanisms that drive na&amp;iuml;ve B cells to become GC B cells and the signals that promote differentiation of GC B cells into the alternative cell fates of memory versus plasma cells. Post-transcriptional control could impart both speed and sensitivity to these processes. This project seeks to understand how B cell differentiation is regulated and to understand the importance of post-transcriptional control in that process.

A key hypothesis to be tested is that post-transcriptional mechanisms contribute to the process of B cell differentiation. Such mechanisms are increasingly being recognised as fundamental to most, if not all, biological processes including cell activation and differentiation. We have observed the rapid expression of genes that regulate mRNA stability and translation by B cells following BCR cross-linking and other stimuli and propose these promote the transition from na&amp;iuml;ve to GC B cell by extinguishing genes which determine the na&amp;iuml;ve B cell phenotype. We propose signals within the germinal centre, such as CD40, which promote the germinal centre phenotype do so, in part, by promoting the expression and function of post-transcriptional regulators. Post-transcriptional regulators expressed at high levels in the GC inhibit plasma cell differentiation by blocking expression of genes critical the plasma cell phenotype. Signals emanating from the BCR, or other receptors, allow plasma cell differentiation by functionally inactivating post-transcriptional regulators. The role of post-transcriptional regulation, at the level of mRNA stability and translation, will be tested using genetic models in which genes can be specifically deleted in resting or activated B cells and B cell differentiation studied at the level of GC/plasma cell differentiation. The programme of work will identify the importance of these genes for B cell responses and provide mechanistic insights by identifying target genes that are regulated at the level of RNA stability and/or translation.</gtr:technicalSummary><gtr:fund><gtr:end>2011-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1405397</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Herbert Irving Comprehensive Cancer Center (HICCC)</gtr:department><gtr:description>Ferrando</gtr:description><gtr:id>C8D067EF-0080-4D6C-8849-7D8E3CAFAA56</gtr:id><gtr:impact>PMID: 20622884</gtr:impact><gtr:outcomeId>GVmbgxGeCRV-1</gtr:outcomeId><gtr:partnerContribution>microarray analysis</gtr:partnerContribution><gtr:piContribution>Microarray analysis of thymic tumours</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genentech</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Genentech</gtr:description><gtr:id>28E3FCBB-7DAE-458E-8CBE-72063ECC4D30</gtr:id><gtr:impact>PMID: 20622884</gtr:impact><gtr:outcomeId>U8uPe3Cyxcd-1</gtr:outcomeId><gtr:partnerContribution>specilized non commercially available reagents</gtr:partnerContribution><gtr:piContribution>Provision of anti-Notch1 blocking antibodies</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Institute for Cancer Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration</gtr:description><gtr:id>822C10A1-C1C7-4A3E-BE70-7C72F0DCBD2F</gtr:id><gtr:impact>PMID: 19715691 PMID: 16137676</gtr:impact><gtr:outcomeId>E6A5196687A-1</gtr:outcomeId><gtr:piContribution>provided know how and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>55DF6FA8-20F5-4734-A4ED-C4BF55101C8D</gtr:id><gtr:impact>lecture on opening of BI BSU

impressed science minister and other policymakers</gtr:impact><gtr:outcomeId>26CF2A35C2C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>890CB0E5-8B05-4AC0-A39C-79AD683A1884</gtr:id><gtr:impact>practical demonstrations and participation in a simple experiment

inspired young people</gtr:impact><gtr:outcomeId>73E3072BBF7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>student visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>4917DEB8-5932-4052-83C0-6680CA07674E</gtr:id><gtr:impact>We have hosted Da Vinci scholars for six month studenships

Students are exceptional and are keen to pursue PhD studies at our institite but have problems getting stipends-we should fix this!</gtr:impact><gtr:outcomeId>3F17E56BD18</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBS/E/B/0000C206 New molecules in signalling pathways for lymphocyte development</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>15E32235-546D-42F4-B4D8-68ECA5F10ADD</gtr:id><gtr:outcomeId>ravtx8aBeiL0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2004-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>floxed alleles of zfp36 family generated (three genes)</gtr:description><gtr:id>404B9F8B-50A4-401B-B1A8-EE1645484FC7</gtr:id><gtr:impact>ongoing reserch has revealed phenotypes of potential clinical relevance. mice have been distributed to other researchers</gtr:impact><gtr:outcomeId>4FF390D7B6B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mutant mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C3AD5D29-F450-4CF9-9844-D040ABA66620</gtr:id><gtr:title>The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa8f768efd8eeee9aa8e93c5656091fd"><gtr:id>aa8f768efd8eeee9aa8e93c5656091fd</gtr:id><gtr:otherNames>Janas ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>i2Hb36zQkV1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>743849F0-A611-49CD-B372-0DE5A2994E11</gtr:id><gtr:title>Rac GTPases play critical roles in early T-cell development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832bc0d1bea41ee61b4ccef724c0bff2"><gtr:id>832bc0d1bea41ee61b4ccef724c0bff2</gtr:id><gtr:otherNames>Dumont C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>oRePr2z76Ev</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D85B6FA-9820-46A9-AD5B-9BB605DBF99E</gtr:id><gtr:title>Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fe6f280971b7a1152ee3e5d2522299a"><gtr:id>1fe6f280971b7a1152ee3e5d2522299a</gtr:id><gtr:otherNames>Kohlhaas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>Mc93i5iDTVv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4500312D-F2C9-4522-92F4-26B8BC3BBE03</gtr:id><gtr:title>Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa8f768efd8eeee9aa8e93c5656091fd"><gtr:id>aa8f768efd8eeee9aa8e93c5656091fd</gtr:id><gtr:otherNames>Janas ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>aLyyy2zghh5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C7D667F-A23F-4B97-B570-59654E11EAEA</gtr:id><gtr:title>RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8990ce80a28677e7463d99b5ba4fb"><gtr:id>04c8990ce80a28677e7463d99b5ba4fb</gtr:id><gtr:otherNames>Galloway A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58ac0530009c59.13314781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F9E621C-D68B-4295-AF15-C63D968842BF</gtr:id><gtr:title>A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/868c5b19c6dbc036b480eb429f5e7601"><gtr:id>868c5b19c6dbc036b480eb429f5e7601</gtr:id><gtr:otherNames>Henderson RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>nuKogEvvyAX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>172C498E-6888-4AF7-9899-8603808E9862</gtr:id><gtr:title>Is transcription the dominant force during dynamic changes in gene expression?</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>SATvbYfX3tj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D4F7F22-0256-4E9D-8159-DED22199D6B3</gtr:id><gtr:title>Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a95ae9ae535288f10635d5864ecb10f"><gtr:id>3a95ae9ae535288f10635d5864ecb10f</gtr:id><gtr:otherNames>Hodson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>PxoMrjSkWDV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCDA3CA7-AE6B-4522-9478-5BF477872CE1</gtr:id><gtr:title>RNA binding proteins as regulators of immune cell biology.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80276f81556671d380e40627c11b5180"><gtr:id>80276f81556671d380e40627c11b5180</gtr:id><gtr:otherNames>Newman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>58ac414f0ac5b0.42336969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93AB7FC8-145B-42D0-AF12-4911CB29954B</gtr:id><gtr:title>Putative GTPase GIMAP1 is critical for the development of mature B and T lymphocytes.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac28bd2782cadb1a774d32861a3d1c76"><gtr:id>ac28bd2782cadb1a774d32861a3d1c76</gtr:id><gtr:otherNames>Saunders A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>hjAXou83GeX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA260341-42E3-4C23-AF11-B2CD85ED8781</gtr:id><gtr:title>Vav GEFs regulate macrophage morphology and adhesion-induced Rac and Rho activation.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ec59d258dabaa0d81f241f979363f5c"><gtr:id>6ec59d258dabaa0d81f241f979363f5c</gtr:id><gtr:otherNames>Bhavsar PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>ZyQAML8NpQt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B60C671D-3B8F-4FB2-84EE-2E02685656C4</gtr:id><gtr:title>Tribbles-2 is a novel regulator of inflammatory activation of monocytes.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af898d4855ca42f1f7dafd8b8c621f31"><gtr:id>af898d4855ca42f1f7dafd8b8c621f31</gtr:id><gtr:otherNames>Eder K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>R5yFfxwqSxD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2686E3A-0D1F-44FD-A58F-E19C81422535</gtr:id><gtr:title>Signaling pathways in T follicular helper cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50acd280a92363cb7e9132d2be7f595b"><gtr:id>50acd280a92363cb7e9132d2be7f595b</gtr:id><gtr:otherNames>Rolf J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>S6EbmVtWkH8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CC4343-DE59-4A44-A93D-33CB78ED506E</gtr:id><gtr:title>T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa3db41d3dbfe556d377475ac88096b5"><gtr:id>aa3db41d3dbfe556d377475ac88096b5</gtr:id><gtr:otherNames>Mart?nez-Mart?n N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>CucY4eVhg3H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B917BC92-C2AB-49EF-B27A-4D2A1AE70120</gtr:id><gtr:title>MicroRNA 125b inhibition of B cell differentiation in germinal centers.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43b0ddcb7c28bfed2c96245ea79e0bec"><gtr:id>43b0ddcb7c28bfed2c96245ea79e0bec</gtr:id><gtr:otherNames>Gururajan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>jLnDVW5DxYk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C2F52F8-95CC-4166-8692-84D5CD4015A6</gtr:id><gtr:title>Regulation of B- and T-cell differentiation by a single microRNA.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>9D9755ED41D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8345CE6D-4D09-4A46-A18E-A1CA85040D7A</gtr:id><gtr:title>B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/548b8ae87236a7967988bd25cf176900"><gtr:id>548b8ae87236a7967988bd25cf176900</gtr:id><gtr:otherNames>Henley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Zqzy2M5abK2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>491D870D-1CAE-4764-9B6C-9D68F3968A07</gtr:id><gtr:title>Detection of protein-protein interactions by ribosome display and protein in situ immobilisation.</gtr:title><gtr:parentPublicationTitle>New biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3056b899bd6dafc64c0b2150e4f403d5"><gtr:id>3056b899bd6dafc64c0b2150e4f403d5</gtr:id><gtr:otherNames>He M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1871-6784</gtr:issn><gtr:outcomeId>SQmPgGxfa9n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C78D789-6038-4CD3-9E4C-82BB496E4FAA</gtr:id><gtr:title>Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50acd280a92363cb7e9132d2be7f595b"><gtr:id>50acd280a92363cb7e9132d2be7f595b</gtr:id><gtr:otherNames>Rolf J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>NPrhWLxsomY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E32961B1-765A-467C-88F2-2709AC0F4E87</gtr:id><gtr:title>Stromal cell-derived factor 1a and CXCR4: newly defined requirements for efficient thymic ?-selection.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa8f768efd8eeee9aa8e93c5656091fd"><gtr:id>aa8f768efd8eeee9aa8e93c5656091fd</gtr:id><gtr:otherNames>Janas ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>JsaK37cZroj</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601618</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>